about
Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)The impact of increased body mass index on systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA XLVI) [corrected].African-American and Hispanic ethnicities, renal involvement and obesity predispose to hypertension in systemic lupus erythematosus: results from LUMINA, a multiethnic cohort (LUMINAXLV)Classification of the vasculitides: are they clinically useful?Prevalence and correlates of metabolic syndrome in patients with rheumatoid arthritis in Argentina.Rate and causes of infliximab discontinuation in patients with rheumatoid arthritis in a private clinical practice.Systemic lupus erythematosus in a multiethnic US cohort (LUMINA L II): relationship between vascular events and the use of hormone replacement therapy in postmenopausal women.Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI) [corrected].Systemic lupus erythematosus in a multiethnic US cohort LUMINA LI: anaemia as a predictor of disease activity and damage accrual.Tendon involvement in patients with gout: an ultrasound study of prevalence.Ozone therapy and lower back pain.Lack of correlation between satisfaction and knowledge in clinical trials participants: a pilot studyIs entheses ultrasound reliable? A reading Latin American exerciseErratum to: Is entheses ultrasound reliable? A reading Latin American exercise[Prevalence of dyslipidemia and elevated cardiovascular risk in patients with rheumatoid arthritis]Differences between active treatment and placebo groups in the study of induction treatment of giant cell arteritis with high-dose glucocorticoids: Comment on the article by Mazlumzadeh et alAssociation of antioxidized low-density lipoprotein antibodies with vascular arterial events and renal manifestations in systemic lupus erythematosus patients: Comment on the article by Frostegård et alSystemic lupus erythematosus in a multiethnic US cohort: Clinical features, course, and outcome in patients with late-onset diseaseSystemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXXI: factors associated with patients being lost to follow-upFactors associated with patients' loss to follow-up after finishing randomized clinical trial participation[Use of infliximab in patients of a rheumatologic center]Soft tissue metastases presenting as greater trochanteric pain syndrome[Mucocutaneous lesions in patients with systemic lupus erythematosus]Lung cavitation in primary antiphospholipid syndrome
P50
Q31107094-4D0D0CA2-7282-4050-A47B-8958CD6E11C6Q31114844-3681C6BA-136F-4959-81F9-89B6B315DB6AQ35953274-2E6ADD48-558B-4BE1-8D63-59E6F1A877ADQ36208055-A299AD84-DD05-40CD-A3BC-E0C28CB91814Q44056335-A0EE1AA5-D6AD-4FC3-91D6-36840D42553FQ46441371-FCC2F5EF-2B0C-4A22-9479-6F4087FB6ED8Q46756368-40701B24-E9A0-47CF-AB17-480FD94C08A8Q46799078-A61EC91B-EA65-4C2F-BA0A-4549BFCC6ED0Q51909862-8AB74C99-C7B7-4B04-B6ED-D266D1638B3DQ53090169-4A211088-6F62-44EB-829B-C31ED9A5AD18Q55041708-54E60106-8B4A-4C3A-98CC-F3C60F910FB1Q56785752-08F513CF-3F73-4B22-ACB8-6A865A79A1E6Q61811880-2B01A88D-C916-48B1-8027-E20852B325A4Q61811884-41F7CDC5-2782-4E33-970F-E2A4DED94D9CQ61811885-910753E7-FA05-42C5-A29B-471FC4A95994Q61811905-75BBAA2D-A3CA-437B-BC61-18A4FD723EFAQ61811915-4C2B0CA5-D6F4-4142-98A5-6D33F6C7D782Q61811922-185D3D24-E4E1-4E75-A7D1-A5BCDE2D1E7BQ61811942-06423B17-7BD8-4A38-B097-70E2FEFFCEB3Q61811952-EED7A94F-8E92-42F3-A53A-06196F76E412Q61811958-5D2B65F5-8DBA-4B7E-AD50-94AEE55ACCADQ61811963-DE4D3300-D478-4645-BE92-2BEA8188674DQ61811968-30205CCF-72FF-4F84-B750-0650165394B2Q61811973-60E5AD70-BCB1-476F-9FB4-F422ABA4DDA5
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ana M Bertoli
@ast
Ana M Bertoli
@en
Ana M Bertoli
@es
Ana M Bertoli
@nl
Ana M Bertoli
@sl
type
label
Ana M Bertoli
@ast
Ana M Bertoli
@en
Ana M Bertoli
@es
Ana M Bertoli
@nl
Ana M Bertoli
@sl
prefLabel
Ana M Bertoli
@ast
Ana M Bertoli
@en
Ana M Bertoli
@es
Ana M Bertoli
@nl
Ana M Bertoli
@sl
P106
P21
P31
P496
0000-0002-9335-075X